Compare Bundamedik Tbk (BMHS) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Merck Tbk. — how do they compare? Bundamedik Tbk trades at Rp175 (market cap 1.51T, 106.3K 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 21.9K 24h volume). The key difference: Bundamedik Tbk and Merck Tbk. are close in size by market cap, and Bundamedik Tbk is more actively traded (106.3K versus 21.9K). Which is the better fit depends on your goals.
| BMHS | MERK | |
|---|---|---|
Market Cap | 1.51T | 1.7T |
Volume | 106.3K | 21.9K |
Lot | 1.06K | 219 |
Turnover | 18.74M | 83.99M |
Average Price | 176.27 | 3,834.93 |
Value | 18.74M | 83.99M |
Indicative Equilibrium Price | 177 | 3,850 |
Indicative Equilibrium Volume | 108 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
